NPTX2 and cognitive dysfunction in Alzheimer's Disease.

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Synaptic Plasticity

Background:

• Alzheimer's disease (AD) is characterized by memory loss linked to synaptic dysfunction.
• Pyramidal neuron connections with parvalbumin (PV) interneurons are crucial for brain network excitability and rhythm.
• The synaptogenic protein NPTX2 and AMPA receptor subunit GluA4 are implicated in excitatory synapse maintenance.

Purpose of the Study:

• To investigate the role of NPTX2 in regulating excitatory synapses on PV interneurons in Alzheimer's disease.
• To determine the impact of NPTX2 deficiency on network function and cognitive deficits in an AD mouse model.
• To assess NPTX2 and GluA4 levels in human AD brain tissue and cerebrospinal fluid (CSF) and correlate them with cognitive function.

Main Methods:

• Utilized a mouse model of AD amyloidosis with NPTX2 gene knockout (Nptx2-/-).
• Examined synaptic function, neuronal excitability, and network rhythmicity in mouse models.
• Analyzed postmortem human AD cortical tissue and CSF samples for NPTX2 and GluA4 expression.
• Correlated CSF NPTX2 levels with cognitive performance and hippocampal volume in human subjects.

Main Results:

• NPTX2 deficiency in AD mice led to reduced GluA4 expression, impaired network rhythmicity, and increased pyramidal neuron excitability.
• Human AD brain cortex showed significant reductions in NPTX2 and corresponding decreases in GluA4.
• Lower NPTX2 levels in human CSF correlated with poorer cognitive performance and reduced hippocampal volume in AD patients.

Conclusions:

• Failure of adaptive control in pyramidal neuron-PV interneuron circuits is a key mechanism in AD pathophysiology.
• NPTX2 plays a critical role in maintaining excitatory synapses on PV interneurons, and its reduction contributes to cognitive impairment in AD.
• NPTX2 levels in CSF may serve as a potential biomarker for AD progression and cognitive status.